Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
Post-market: 5.13-0.1894-3.56%19:59 EDT
Volume:60.53M
Turnover:340.61M
Market Cap:2.31B
PE:-2.95
High:6.20
Open:6.04
Low:5.30
Close:5.91
52wk High:12.36
52wk Low:3.79
Shares:434.15M
Float Shares:415.00M
Volume Ratio:1.15
T/O Rate:14.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8042
EPS(LYR):-1.6909
ROE:-86.34%
ROA:-39.08%
PB:2.51
PE(LYR):-3.15

Loading ...

Recursion Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
May 06

Shares of Recursion Pharmaceuticals Slide After 1Q Loss

Dow Jones
·
May 06

Recursion Pharmaceuticals Q1 Loss Widens, Revenue Increases

MT Newswires Live
·
May 05

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Revenue $14.7M, vs. FactSet Est of $15M

MT Newswires Live
·
May 05

Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q1 Net Loss $0.50 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live
·
May 05

Recursion Pharmaceuticals Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.74M Miss $18.12M Estimate

Benzinga
·
May 05

Recursion Pharmaceuticals Reports Promising Early Results for Familial Adenomatous Polyposis Drug Trial

MT Newswires Live
·
May 05

Recursion Pharmaceuticals Announces Promising Preliminary Results in Phase 1b/2 Trial of REC-4881 for Familial Adenomatous Polyposis

Reuters
·
May 05

Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.

Tiger Newspress
·
May 02

Nvidia-Related Stocks Shined. Aurora Jumped 8%; CoreWeave And WeRide Up 7%; Innoviz Up 4%; Nvidia Up 2%

Tiger Newspress
·
May 02

Nvidia-Related and AI-Related Stocks Shined. CoreWeave and Applied Digital up 10%; AppLovin up 6%; Nvidia up 4%

Tiger Newspress
·
May 01

Nvidia-Concept Stocks Shined. CoreWeave Up 8%; Nebius Up 6%; Innoviz Up 5%; Nvidia Up 3%

Tiger Newspress
·
May 01

Press Release: Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th

Dow Jones
·
Apr 28

BRIEF-Healthverity Partners With Recursion To Enhance Clinical Trial Analytics With Real-World Data

Reuters
·
Apr 16